The effect of corticosteroid treatment on pulmonary function in adults with Duchenne muscular dystrophy

被引：0

作者：

Pietrusz, A. ^{[1
]}

Astin, R. ^{[2
]}

Guglieri, M. ^{[3
,4
]}

Desikan, M. ^{[2
]}

Waller, K. ^{[3
,4
]}

Chapman, S. ^{[3
,4
]}

Schiava, M. ^{[3
,4
]}

Brady, S. ^{[5
]}

Soleimani, B. ^{[5
]}

Freebody, J. ^{[5
]}

Nickol, A. ^{[6
]}

Ramdharry, G. ^{[2
]}

Muntoni, F. ^{[7
,8
]}

Quinlivan, R. ^{[1
,2
]}

机构：

[1] UCL Queen Sq Inst Neurol, Dept Neuromusc Dis, London, England

[2] Nat Hosp Neurol Neurosurg, London, England

[3] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Newcastle, England

[4] Newcastle Hosp NHS Fdn Trust, Newcastle, England

[5] John Radcliffe Hosp, Oxford Muscle Serv, Oxford, England

[6] Oxford Univ Hosp NHS Trust, Oxford, England

[7] NHS Fdn Trust, Dubowitz Neuromusc Ctr, UCL Gt Ormond St Inst, London, England

[8] NHS Fdn Trust, Gt Ormond St Hosp Children, London, England

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.166

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P39

引用

页码：S106 / S107

页数：2

共 50 条

[41] Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
King, W. M.
Ruttencutter, R.
Nagaraja, H. N.
Matkovic, V.
Landoll, J.
Hoyle, C.
Mendell, J. R.
Kissel, J. T.
NEUROLOGY, 2007, 68 (19) : 1607 - 1613
[42] The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
Szabo, Shelagh M.
Salhany, Renna M.
Deighton, Alison
Harwood, Meagan
Mah, Jean
Gooch, Katherine L.
ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
[43] Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation
Kim, Sunkyung
Campbell, Kimberly A.
Fox, Deborah J.
Matthews, Dennis J.
Valdez, Rodolfo
JOURNAL OF CHILD NEUROLOGY, 2015, 30 (10) : 1275 - 1280
[44] 10 years follow-up of early corticosteroid treatment of Duchenne muscular dystrophy
Merlini, L.
Malaspina, E.
Gennari, M.
Cicognani, A.
Franzoni, E.
Talim, B.
NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 772 - 772
[45] The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
Shelagh M. Szabo
Renna M. Salhany
Alison Deighton
Meagan Harwood
Jean Mah
Katherine L. Gooch
Orphanet Journal of Rare Diseases, 16
[46] Pulmonary and nonpulmonary alterations in Duchenne muscular dystrophy
Rosa Gueell, Maria
Avendano, Monica
Fraser, Janet
Goldstein, Roger
ARCHIVOS DE BRONCONEUMOLOGIA, 2007, 43 (10): : 557 - 561
[47] Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy
Kim, Sunkyung
Zhu, Yong
Romitti, Paul A.
Fox, Deborah J.
Sheehan, Daniel W.
Valdez, Rodolfo
Matthews, Dennis
Barber, Brent J.
STARnet, M. D.
NEUROMUSCULAR DISORDERS, 2017, 27 (08) : 730 - 737
[48] Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy
Lit, L.
Sharp, F. R.
Apperson, M.
Liu, D. Z.
Walker, W. L.
Liao, I.
Xu, H.
Ander, B. P.
Wong, B.
PHARMACOGENOMICS JOURNAL, 2009, 9 (06): : 411 - 418
[49] Update on the Treatment of Duchenne Muscular Dystrophy
Rodino-Klapac, Louise R.
Mendell, Jerry R.
Sahenk, Zarife
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (03)
[50] Treatment options for Duchenne muscular dystrophy
Ciafaloni, Emma
Moxey, Richard T.
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2008, 10 (02) : 86 - 93

← 1 2 3 4 5 →